Show Summary Details
Page of

(p. 211) Medications 

(p. 211) Medications
(p. 211) Medications

Michelle G. Craske

, and David H. Barlow

Page of

PRINTED FROM OXFORD CLINICAL PSYCHOLOGY ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Clinical Psychology Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 May 2022

This chapter discusses medications for anxiety and panic. In the workbook, medication is not described as a more or less effective form of treatment in comparison to cognitive behavioral therapy (CBT) but as a more or less appropriate treatment dependent on different beliefs and life circumstances. Medications are described, so that clients may understand their effectiveness and side effects, as well as issues in discontinuing medications. The chapter then details a program to help wean clients from medication as part of an ongoing treatment regimen. In this program, withdrawal effects from medication, particularly benzodiazepines, are managed using the skills taught in the workbook. However, the issue of combining medications with CBT of the sort outlined in this guide and the corresponding workbook is complicated. There is some evidence that benzodiazepines do not combine well with CBT, and there is some evidence that, overall, the combination of medications with CBT is less efficacious in the long term than CBT alone.

Access to the complete content on Oxford Clinical Psychology requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.